2025-12-19 - Analysis Report
Here's a breakdown of Hims & Hers Health Inc. (HIMS) based on the provided data:

**Company Overview:** Hims & Hers Health Inc. is a telehealth company that offers personalized health and wellness products and services online.

**1) Return Rate Comparison:**

*   **HIMS Cumulative Return:** 124.48%
*   **VOO (S&P 500) Cumulative Return:** 73.05%
*   **Divergence:** 68.3 (Relative Divergence: 37.9)

**Analysis:** HIMS has significantly outperformed the S&P 500 over the observed period. However, the relative divergence of 37.9 suggests that while currently positive, the divergence isn't exceptionally high within its historical range.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD    | Alpha   | Beta  | Cap(B) |
|------------|---------|--------|---------|-------|--------|
| 2019-2021  | -42.0%  | 74.4%  | -81.0%  | 0.0   | 1.5    |
| 2020-2022  | -19.0%  | 78.6%  | -18.0%  | -0.0  | 1.5    |
| 2021-2023  | -65.0%  | 78.6%  | -67.0%  | -0.1  | 2.0    |
| 2022-2024  | 119.0%  | 79.4%  | 98.0%   | -0.0  | 5.5    |
| 2023-2025  | 129.0%  | 80.8%  | 65.0%   | 0.1   | 7.9    |

**Analysis:**

*   **CAGR:** The CAGR has fluctuated significantly, showing strong growth in recent periods (2022-2025, 2023-2025) but substantial declines in prior periods.
*   **MDD:** The Maximum Drawdown (MDD) is consistently high, indicating significant volatility and risk.
*   **Alpha:** Alpha, representing excess return compared to the market, shows a similar trend to CAGR. Alpha has become significantly positive in the most recent periods, indicating outperformance.
*   **Beta:** Beta is consistently around 0, suggesting that the stock's price does not move in tandem with the market.
*   **Cap(B):** The company's market capitalization has been increasing, suggesting growth.

**2) Recent Stock Price Fluctuations:**

*   **Current Price:** 34.77
*   **Previous Close:** 34.97
*   **Change:** -0.57
*   **5-day SMA:** 36.012
*   **20-day SMA:** 37.258
*   **60-day SMA:** 44.8839

**Analysis:** The current price is slightly below the previous close, indicating a recent dip. The 5-day and 20-day SMAs are below the 60-day SMA, suggesting a short-term downward trend.

**3) Technical Indicators:**

*   **Market Risk Indicator (MRI):** 0.7 (Medium Investment)
*   **RSI:** 32.66 (Approaching Oversold)
*   **PPO:** 0.0261
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (27 shares - Very Safe - MRI:0.90)
*   **Recent Relative Divergence Change (20 days):** 1.1 (+) (Short-term increase)
*   **Expected Return:** 24.2% (Long-term)

**Analysis:**

*   The MRI suggests a medium investment risk level.
*   The RSI is approaching oversold territory (below 30), which *could* indicate a potential buying opportunity if you believe in a rebound.
*   The Hybrid Signal suggests buying.
*   The recent increase in relative divergence points to a short-term upward trend.
*   The expected return of 24.2% is optimistic, suggesting strong potential growth over the long term. However, consider the risks indicated by the MDD and MRI.
*   The change in recent price is relatively small, indicating that the daily stock fluctuations are not so great.

**4) Recent News & Significant Events:**

*   **Positive Coverage:** Articles highlight Hims & Hers' technology-driven care scaling, profitability evolution, and partnerships, contributing to a year-to-date price surge.
*   **Share Repurchase Program:** A $250 million share repurchase program was authorized, signaling confidence in the company's future and potentially increasing shareholder value.
*   **Analyst Activity:** An article notes recent volatility and expansion. A company executive (Michael Chi) sold shares.
*   **Negative Coverage:** An article asks "Why Is Hims & Hers Stock Falling, and Should Investors Buy the Dip?" This suggests some concern about recent performance.

**Analysis:** The news is mixed, with positive reports of scaling and partnerships balanced by concerns about recent price drops and insider selling. The share repurchase program is a positive signal.

**4-2) Analyst Opinions:**

*   **Consensus:** Hold
*   **Mean Rating:** 2.93 (~Hold)
*   **Opinions:** 12
*   **Target Price (avg/high/low):** 44.67 / 85.00 / 25.00

**Analysis:** Analysts, on average, have a "Hold" rating on the stock. The average target price suggests potential upside, but there's a wide range in target prices, indicating uncertainty among analysts.

**5) Recent Earnings Analysis:**

| Date       | EPS   | Revenue  |
|------------|-------|----------|
| 2025-11-03 | 0.07  | 0.60 B$  |
| 2025-08-04 | 0.19  | 0.54 B$  |
| 2025-05-05 | 0.22  | 0.59 B$  |
| 2024-11-04 | 0.35  | 0.40 B$  |
| 2025-11-03 | 0.35  | 0.40 B$  |

**Analysis:** Revenue has been growing steadily. It is important to note that the last two rows duplicate a date (2025-11-03) and have identical values for EPS and Revenue, thus one of them should be 2024-08-04.

**6) Financial Information:**

**Revenue and Profitability:**

| Quarter      | Revenue  | Profit Margin |
|--------------|----------|---------------|
| 2025-09-30   | $0.60B   | 73.80%        |
| 2025-06-30   | $0.54B   | 76.39%        |
| 2025-03-31   | $0.59B   | 73.50%        |
| 2024-12-31   | $0.48B   | 76.81%        |
| 2024-09-30   | $0.40B   | 79.16%        |

**Analysis:** Revenue is showing a positive trend. Profit margins are consistently high, indicating strong profitability.

**Capital and Profitability:**

| Quarter      | Equity   | ROE    |
|--------------|----------|--------|
| 2025-09-30   | $0.58B   | 2.72%  |
| 2025-06-30   | $0.56B   | 7.55%  |
| 2025-03-31   | $0.55B   | 9.01%  |
| 2024-12-31   | $0.48B   | 5.46%  |
| 2024-09-30   | $0.44B   | 17.18% |

**Analysis:** Equity is increasing, indicating growing shareholder value. ROE has fluctuated, with a noticeable decrease in the most recent quarter.

**7) Comprehensive Analysis:**

Hims & Hers Health Inc. (HIMS) presents a mixed picture.

**Positives:**

*   **Strong Revenue Growth:** Revenue is consistently increasing, showing good business momentum.
*   **High Profit Margins:**  Consistently high profit margins indicate efficient operations.
*   **Outperformance:** HIMS has significantly outperformed the S&P 500 over the long term.
*   **Positive Long-Term Expected Return:** An expected return of 24.2% is enticing.
*   **Share Repurchase Program:** This indicates management confidence and can boost share price.

**Negatives/Concerns:**

*   **High Volatility (MDD):** The stock experiences significant price swings, making it risky.
*   **Recent Price Dip:** The current price is below recent SMA's and the previous close, indicating a short-term downward trend.
*   **Mixed News Coverage:**  Some articles question recent price drops.
*   **Analyst Consensus: "Hold":** Analysts are not strongly bullish.
*   **Decreasing ROE (Recent Quarter):**  The recent drop in ROE is concerning and warrants further investigation.
*   **Small price fluctuation recently.**

**Overall:**

HIMS is a growth company with strong potential but also significant risks. Investors should be aware of the high volatility and carefully consider their risk tolerance. The recent price dip and mixed news suggest caution. Further investigation into the recent ROE decrease and the reasons behind the analyst "Hold" ratings is recommended before making an investment decision.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.